Unverified50% confidenceSolutionExact time
A reasonable approach is to determine the optimal oversampling level through small-scale experiments for the target disease and model architecture, while monitoring disease-level performance changes.
1
Sources
50%
Confidence
Long-term
Relevance
10/19/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedThe study evaluated large models using real clinical cases rather than standardized exam questions in order to reflect the capability boundaries of models in practical applications.74% similarUnverifiedThe study stresses that the amount and benefit of synthetic data must be evaluated separately for each disease and each training setting, rather than assuming 'the more the better'.72% similarUnverifiedDuring development, synthetic samples should be used instead of real patient data to validate the tools, and both successful and uncertain results should be checked, comparing reported counts against the generated audit rows.72% similarUnverified医学AI临床验证的性能基准须针对目标人群建立，不能直接沿用公开数据集的评测结果，需通过多中心前瞻性研究证明安全性和有效性72% similarUnverifiedThe MIMIC dataset primarily originates from intensive care settings, and the model's generalizability in broader clinical environments remains to be examined.72% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1065736API
curl https://kongchang.com/api/v1/knowledge/claims/1065736MCP
get_claim(id=1065736)